相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis
Kwonmok Ko et al.
JOURNAL OF AFFECTIVE DISORDERS (2023)
Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms
Patrick D. Skosnik et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2023)
Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development
R. C. Van Court et al.
FUNGAL BIOLOGY (2022)
Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice
Christopher W. Thomas et al.
TRANSLATIONAL PSYCHIATRY (2022)
Tabernaemontana arborea and ibogaine induce paroxysmal EEG activity in freely moving mice: Involvement of serotonin 5-HT1A receptors
Maria Eva Gonzalez-Trujano et al.
NEUROTOXICOLOGY (2022)
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Federico Cavanna et al.
TRANSLATIONAL PSYCHIATRY (2022)
Pharmacological and toxicological effects of Ruta chalepensis L. on experimentally induced seizures and electroencephalographic spectral power in mice
M. E. Gonzalez-Trujano et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Behavioral arrest and a characteristic slow waveform are hallmark responses to selective 5-HT2A receptor activation
April Contreras et al.
SCIENTIFIC REPORTS (2021)
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Damian F. Santomauro et al.
LANCET (2021)
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
Guy A. Higgins et al.
FRONTIERS IN PHARMACOLOGY (2021)
Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors
Robertas Strumila et al.
PHARMACEUTICALS (2021)
The Therapeutic Potential of Psilocybin
Henry Lowe et al.
MOLECULES (2021)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in Magic Mushrooms
Felix Blei et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use
Carl A. Roberts et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials
Ana Sofia Vargas et al.
BIOMEDICINES (2020)
Aqueous Extract of Pomegranate Alone or in Combination with Citalopram Produces Antidepressant-Like Effects in an Animal Model of Menopause: Participation of Estrogen Receptors
Brenda Valdes-Sustaita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala
Alberto Hernandez-Leon et al.
BEHAVIOURAL PHARMACOLOGY (2017)
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Ricardo Jorge Dinis-Oliveira
DRUG METABOLISM REVIEWS (2017)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
Alize J. Ferrari et al.
PLOS MEDICINE (2013)
Current findings, future trends, and unsolved problems in studies of medicinal mushrooms
Solomon P. Wasser
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
Local sleep in awake rats
Vladyslav V. Vyazovskiy et al.
NATURE (2011)
Harm potential of magic mushroom use: A review
Jan van Amsterdam et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
Lakshmi N. Ravindran et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light Conditions
Hasan Rafati et al.
INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS (2009)
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
L Prut et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines
JB Blair et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)